Oaktree Acquisition Corp. III Life Sciences (OACC) EBITDA (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences (OACC) reported EBITDA of -$456538.0 for Q1 2026, down 2.64% on a YoY basis from -$468910.1 in Q1 2025, and down 78.69% quarter-over-quarter from -$255496.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACC) EBITDA (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences has reported EBITDA for 2 years, with the latest figure at -$456538.0 in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 2.64% year-over-year to -$456538.0; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (changed N/A YoY), and the FY2025 full-year result was -$1.2 million, down 239.87% from the prior year.
- EBITDA for Q1 2026 stood at -$456538.0, down from -$255496.0 in the prior quarter.
- The five-year high for EBITDA was -$225579.0 in Q3 2025, with the low at -$456538.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -427,850.00 |
| 2 | Berto Acquisition | 312.76 Mn | 312.76 Mn | - | -482,100.00 |
| 3 | Centurion Acquisition | 312.51 Mn | 312.51 Mn | - | -201,744.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -1.15 Mn |
| 5 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -225,545.00 |
| 6 | Agriculture & Natural Solutions Acquisition | 303.01 Mn | 303.01 Mn | - | -612,993.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | -198,194.00 |
| 8 | Soulpower Acquisition | 265.17 Mn | 265.17 Mn | - | 685,558.00 |
| 9 | BTC Development | 261.90 Mn | 261.90 Mn | - | -540,761.00 |
| 10 | Oaktree Acquisition Corp. III Life Sciences | 57.34 Mn | 57.34 Mn | - | -456,538.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -456,538.00 |
| Dec 31, 2025 | -255,496.00 |
| Sep 30, 2025 | -225,579.00 |
| Jun 30, 2025 | -269,810.00 |
| Mar 31, 2025 | -444,802.00 |